THBS2 and colorectal carcinoma: For instance, Deng, Liu & Wang (2021) reported that elevated THBS2 expression correlates with shorter overall and disease-free survival, alongside a positive association with immune infiltrates in CRC, supporting its role as both a prognostic and immunological biomarker.